{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:15:24Z","timestamp":1792163724403,"version":"4.4.0"},"reference-count":52,"publisher":"Cambridge University Press (CUP)","issue":"5","license":[{"start":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T00:00:00Z","timestamp":1482364800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Spectr."],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:p>Irreversible monoamine oxidase inhibitor (MAOI) antidepressants have significant efficacy in treatment-resistant unipolar depression, but in some instances patients may not achieve remission. Among the adjunctive and augmentation strategies, certain second-generation antipsychotics (SGAs) have approval for inadequate responders to antidepressant therapy, including aripiprazole, brexpiprazole, and quetiapine, with lurasidone and the olanzapine\/fluoxetine combination indicated for bipolar depression. Clinicians may eschew SGA options in part due to the limited literature on SGA\u2013MAOI combinations, with only one published case involving aripiprazole, and none for olanzapine, lurasidone, or brexpiprazole. In addition to the limited publication history on SGA\u2013MAOI treatment, clinicians may also be deterred by uncertainty regarding SGA mechanisms and the risk of serotonin syndrome or other adverse outcomes. This paper describes the case of a 54-year-old male with a history of psychotic unipolar depression treated with a combination of phenelzine, aripiprazole, and quetiapine, and reviews the 12 published cases of SGA\u2013MAOI combination therapy with a focus on the pharmacological basis for serotonin syndrome, and the SGA mechanisms that should not be associated with a risk for this syndrome.<\/jats:p>","DOI":"10.1017\/s1092852916000821","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T05:12:35Z","timestamp":1482383555000},"page":"391-396","source":"Crossref","is-referenced-by-count":12,"title":["Augmentation of phenelzine with aripiprazole and quetiapine in a treatment-resistant patient with psychotic unipolar depression: case report and literature review"],"prefix":"10.1017","volume":"22","author":[{"given":"Jonathan M.","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Proctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2016,12,22]]},"reference":[{"key":"S1092852916000821_ref34","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198902000-00009"},{"key":"S1092852916000821_ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1626"},{"key":"S1092852916000821_ref47","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(98)00090-6"},{"key":"S1092852916000821_ref38","first-page":"173","article-title":"Clinical manifestation of confusion and hallucinations caused by an interaction between rasagiline and escitalopram [in Spanish]","volume":"33","author":"Bandres Liso","year":"2009","journal-title":"Farm Hosp"},{"key":"S1092852916000821_ref37","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1500"},{"key":"S1092852916000821_ref49","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13070984"},{"key":"S1092852916000821_ref30","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(88)90111-X"},{"key":"S1092852916000821_ref27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6201.1315"},{"key":"S1092852916000821_ref14","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181e63033"},{"key":"S1092852916000821_ref5","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1576"},{"key":"S1092852916000821_ref28","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198109000-00002"},{"key":"S1092852916000821_ref48","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006296151"},{"key":"S1092852916000821_ref36","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n1113"},{"key":"S1092852916000821_ref45","first-page":"49","article-title":"Reboxetine prevents the tranylcypromine-induced increase in tyramine levels in rat heart","volume":"411","author":"Dostert","year":"1994","journal-title":"J Neural Transm Suppl"},{"key":"S1092852916000821_ref15","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000264970.54711.43"},{"key":"S1092852916000821_ref41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1358\/dot.2016.52.2.2461868","article-title":"Cariprazine: new dopamine biased agonist for neuropsychiatric disorders","volume":"52","author":"De Deurwaerdere","year":"2016","journal-title":"Drugs of Today (Barc)"},{"key":"S1092852916000821_ref24","first-page":"48","article-title":"The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and Triptans: an analysis of the 29 case reports","volume":"9","author":"Evans","year":"2007","journal-title":"MedGenMed"},{"key":"S1092852916000821_ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199612000-00011"},{"key":"S1092852916000821_ref42","doi-asserted-by":"publisher","DOI":"10.3371\/CSRP.MCCI.010316"},{"key":"S1092852916000821_ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052964"},{"key":"S1092852916000821_ref7","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2015.51.7.2358605"},{"key":"S1092852916000821_ref9","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900021386"},{"key":"S1092852916000821_ref33","first-page":"182","article-title":"Combined use of trazodone and phenelzine in depression: case report","volume":"45","author":"Zetin","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"S1092852916000821_ref52","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15m10070"},{"key":"S1092852916000821_ref1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.9.1519"},{"key":"S1092852916000821_ref46","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31820469ea"},{"key":"S1092852916000821_ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041867"},{"key":"S1092852916000821_ref43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2010.00217.x"},{"key":"S1092852916000821_ref29","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1176\/ajp.140.10.1384a","article-title":"Combined tricyclic and MAOI treatment of depressed patients","volume":"140","author":"Raskin","year":"1983","journal-title":"Am J Psychiatry"},{"key":"S1092852916000821_ref44","first-page":"65","article-title":"Toxicity by interaction of tricyclic antidepressant and monoamine oxidase inhibitor","volume":"117","author":"Rom","year":"1972","journal-title":"Calif Med"},{"key":"S1092852916000821_ref40","first-page":"1254","article-title":"Combination of escitalopram- and rasagiline-induced serotonin syndrome: a case report and review literature","volume":"98","author":"Suphanklang","year":"2015","journal-title":"J Med Assoc Thai"},{"key":"S1092852916000821_ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0097-3"},{"key":"S1092852916000821_ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200008000-00020"},{"key":"S1092852916000821_ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-013-0386-3"},{"key":"S1092852916000821_ref6","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2010.07.2174"},{"key":"S1092852916000821_ref21","first-page":"1","article-title":"Monoamine oxidase inhibitors: a review concerning dietary tyramine and drug interactions","volume":"1","author":"Gillman","year":"2016","journal-title":"PsychoTrop Res"},{"key":"S1092852916000821_ref35","first-page":"298","article-title":"Low-dose trazodone as a hypnotic in patients treated with MAOIs and other psychotropics: a pilot study","volume":"51","author":"Jacobsen","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"S1092852916000821_ref39","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25416"},{"key":"S1092852916000821_ref10","first-page":"107","article-title":"Een psychotische depressie en onvoldoende effect van farmacotherapie en elektroconvulsietherapie: wat zijn de volgende optie [in German] [The treatment of psychotic depression in patients insufficiently responsive to conventional medication and electroconvulsive therapy; what are the options?]","volume":"50","author":"Koerhuis","year":"2008","journal-title":"Tijdschr Psychiatr"},{"key":"S1092852916000821_ref17","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199404000-00010"},{"key":"S1092852916000821_ref26","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1971.01750120025005"},{"key":"S1092852916000821_ref8","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G416"},{"key":"S1092852916000821_ref19","doi-asserted-by":"publisher","DOI":"10.1177\/106002809402800610"},{"key":"S1092852916000821_ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2010.01691.x"},{"key":"S1092852916000821_ref31","first-page":"336","article-title":"Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant","volume":"55","author":"McGrath","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"S1092852916000821_ref51","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15060770"},{"key":"S1092852916000821_ref50","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13070985"},{"key":"S1092852916000821_ref32","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(95)00016-G"},{"key":"S1092852916000821_ref16","article-title":"Reducing the burden of difficult-to-treat major depressive disorder: revisiting monoamine oxidase inhibitor therapy","volume":"15","author":"Culpepper","year":"2013","journal-title":"Prim Care Companion CNS Disord"},{"key":"S1092852916000821_ref18","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.1.274"},{"key":"S1092852916000821_ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-013-0403-2"},{"key":"S1092852916000821_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(03)00090-7"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852916000821","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T18:42:28Z","timestamp":1555440148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852916000821\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,22]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1092852916000821"],"URL":"https:\/\/doi.org\/10.1017\/s1092852916000821","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,22]]}}}